Skeletal Dysplasia Follow-up
- Author: Harold Chen, MD, MS, FAAP, FACMG; Chief Editor: Bruce Buehler, MD more...
Further Outpatient Care
- To prevent inappropriate counseling, do not offer genetic counseling until the diagnosis is confirmed by a clinician experienced in skeletal dysplasias.
- In an autosomal dominant disorder, the risk that an affected parent will have an affected child is 50%. For unaffected parents, the risk is negligible, except when germinal mosaicism occurs.
- When both parents have the same autosomal dominant condition, such as achondroplasia, the offspring have (1) a 25% chance of having normal stature, (2) a 50% chance of having typical achondroplasia, and (3) a 25% chance of having homozygous achondroplasia, which is lethal.
- When one parent has an autosomal dominant skeletal dysplasia condition (eg, achondroplasia) and the other parent has a different autosomal dominant skeletal dysplasia (eg, hypochondroplasia) the offspring have (1) a 25% chance of having normal stature, (2) a 25% chance of having achondroplasia, (3) a 25% chance of having hypochondroplasia, and (4) a 25% chance of having heterozygous for the achondroplasia-hypochondroplasia compound with intermediate severity.
- In an autosomal recessive disorder, the parents are obligatory carriers with a 25% risk that each child will have the disorder.
- In an X-linked recessive disorder in which the mother is a carrier, a male child has a 50% risk of being affected and a female child has a 50% risk of being a carrier.
- Assistance with research and diagnosis is available from various organizations. Cedars-Sinai Medical Center is a referral center for the diagnosis, management, and etiology of skeletal dysplasia. The contact information is as follows: International Skeletal Dysplasia Registry
- Medical Genetics Institute
- 8700 Beverly Blvd
- West Tower, Suite 665
- Los Angeles, CA 90048
- Phone: 800-CEDARS-1 (800-233-2771) or 310-423-9915
- email: MaryAnn.Priore@cshs.org
Complications
- Intrauterine complications: Polyhydramnios and fetal hydrops are typically seen in patients with lethal types of chondrodystrophy, such as achondrogenesis or thanatophoric dysplasia. Occasionally, polyhydramnios may be seen in patients with nonlethal types of chondrodystrophy, such as achondroplasia.
- Respiratory complications: Respiratory distress secondary to small chest, small lungs, small or collapsing trachea, or small upper airway is seen in patients with many types of chondrodystrophy, such as asphyxiating thoracic dystrophy. Infants may snore, may have upper airway obstruction, or may experience hypoxic episodes.
- CNS complications: Hydrocephalus can occur in several types of skeletal dysplasia, notably in achondroplasia, metatropic dysplasia, and other conditions that affect the base of the skull, resulting in small foramen magnum and jugular foramen.
- Skeletal complications: Instability of the C1-C2 cervical spine that leads to spinal cord compression or nerve damage may be observed in patients with several types of chondrodystrophy, such as achondroplasia, SED congenita, and Morquio syndrome. Vertebral abnormalities, hip dysplasia, tight and loose joints, osteoarthritis, bowed legs, and fractures may vary.
- Muscular complications: Truncal hypotonia may lead to kyphoscoliosis in infants with achondroplasia or mucopolysaccharidoses. Thoracolumbar kyphosis may revert to marked lordosis in achondroplasia.
- Otolaryngologic complications: Progressive deafness is associated with repeated middle ear infections in patients with diastrophic dysplasia and achondroplasia. Hearing loss can be conductive or neurosensory in origin.
- Ophthalmologic complications: Myopia may predispose the patient to retinal detachment in Kniest dysplasia and SED congenita.
- Dental complications: Malocclusions, dental crowding, and structural abnormalities of teeth may be present in patients with many types of chondrodystrophy.
- Nutritional complications: Obesity is often a problem in patients with some types of chondrodystrophy, especially achondroplasia.
- Other complications
- Anesthesia can be a problem in patients with some chondrodysplasias.
- Unstable cervical vertebrae should be excluded.
- Malignant hyperthermia may occur during anesthesia in patients with some types of chondrodysplasia, such as osteogenesis imperfecta.
- Numerous obstetric and gynecologic problems are common in women with disproportionately short stature. Cesarean delivery of a baby may be required because of a contracted pelvis in the mother.
Prognosis
- Although certain skeletal dysplasias are lethal in the newborn or infancy periods, patients with other types of skeletal dysplasia have normal or near-normal life expectancy. For patients with nonlethal skeletal dysplasias, prognosis depends on the degree of skeletal abnormalities and concomitant anomalies.
- Some patients may have difficulty finding a marital partner.
- Men with skeletal dysplasia complain less often of psychiatric symptoms and feel less stigmatized than do women.
- Medical and social aspects of the life course for adults with a skeletal dysplasia include the following:[28]
- Overall, strong evidence suggests some barriers to equal opportunity in education and employment, and these, together with increased social isolation, are highly likely to exert a strong influence on financial situation and, therefore, on quality of life. All persons with skeletal dysplasia are physically impaired by virtue of the dysplasia. Only those with severe physical abnormalities are hampered in obtaining education and employment.
- A substantial gap is observed in knowledge of the medical and social experiences of adults with skeletal dysplasias.
- The relevance of the disability label is an important issue to many people with disabling conditions. It may be necessary to "come out" as disabled in order to qualify for support such as Disability Living Allowance (DLA).
- Only by adopting a more stringent methodological approach to future research will it be possible to provide the robust evidence-base needed to inform future health and social service provision, as well as offering material for education and training purposes.
Patient Education
The birth of a child with a skeletal dysplasia is an emotionally difficult experience for parents. The term "dwarf" has especially negative connotations; thus, skeletal dysplasia is the preferred term for discussing these disorders. Up-to-date information and resources pertaining to skeletal dysplasia should be made available to families. The following resources may help parents meet other parents of children with skeletal dysplasia who can offer support and realistic appraisal of the implications:
- 5289 NE Elam Young Parkway
- Suite F-100
- Hillsboro, OR 97124
- Phone: 888-LPA-2001
- email: info@lpaonline.org
- 997 Glen Cove Ave
- Suite 5
- Glen Head, NY 11545
- Phone: 800-451-6434
- email: hgf1@hgfound.org
- The Magic Foundation
- 6645 W. North Avenue
- Oak Park, IL 60302
- Phone: 800-362-4423
- email: mary@magicfoundation.org
- 55 Kenosia Avenue
- PO Box 1968
- Danbury, CT 06813-1968
- Phone: 800-999-6673
- email: orphan@rarediseases.org
International Working Group on Constitutional Diseases of Bone. International nomenclature and classification of the osteochondrodysplasias (1997). Am J Med Genet. Oct 12 1998;79(5):376-82. [Medline].
Ikegawa S. Genetic analysis of skeletal dysplasia: recent advances and perspectives in the post-genome-sequence era. J Hum Genet. 2006;51(7):581-6. [Medline].
Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet. Mar 2002;30(3):306-10. [Medline].
Alman BA. Skeletal dysplasias and the growth plate. Clin Genet. Jan 2008;73(1):24-30. [Medline].
Kronenberg HM. Developmental regulation of the growth plate. Nature. May 15 2003;423(6937):332-6. [Medline].
Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. Jul 29 1994;78(2):335-42. [Medline].
Blomstrand S, Claesson I, Save-Soderbergh J. A case of lethal congenital dwarfism with accelerated skeletal maturation. Pediatr Radiol. 1985;15(2):141-3. [Medline].
Gordon SL, Varano LA, Alandete A, Maisels MJ. Jansen's metaphyseal dysostosis. Pediatrics. Oct 1976;58(4):556-60. [Medline].
Jobert AS, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest. Jul 1 1998;102(1):34-40. [Medline].
Schipani E, Kruse K, Jüppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. Apr 7 1995;268(5207):98-100. [Medline].
Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. May 30 1997;89(5):773-9. [Medline].
Baitner AC, Maurer SG, Gruen MB, Di Cesare PE. The genetic basis of the osteochondrodysplasias. J Pediatr Orthop. Sep-Oct 2000;20(5):594-605. [Medline].
Superti-Furga A, Bonafe L, Rimoin DL. Molecular-pathogenetic classification of genetic disorders of the skeleton. Am J Med Genet. Winter 2001;106(4):282-93. [Medline].
Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS, Alanay Y. The skeletal dysplasias: clinical-molecular correlations. Ann N Y Acad Sci. Nov 2007;1117:302-9. [Medline].
Superti-Furga A, Unger S, and the Nosology Group of theInternational Skeletal Dysplasia Society. Nosology and classification of geneticskeletal disorders: 2006 revision. Am J Med Genet Part A. 2007;143A:1-18.
Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet Part A. 2011;155:943-968.
Sillence DO, Rimoin DL. Classification of osteogenesis imperfecta. Lancet. 1978;1:1041-1042.
Sillence DO, Rimoin DL, Danks DM. Clinical variability in osteogenesisimperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser. 1979a;15:113-129.
Stevenson DA, Viskochil DH, Carey JC. Neurofibromatosis type 1 is agenetic skeletal disorder. Am J Med Genet Part A. 2007;143A:2082-2083.
Nishimura G, Hasegawa T, Kinoshita E, et al. Newly recognized syndrome of metaphyseal undermodeling,spondylar dysplasia, and overgrowth: Report of two adolescents and a child. Am J Med Genet Part A. 2004;128A:204-208.
Schmidt H, Kammer B, Grasser M, et al. Endochondral gigantism: A newly recognized skeletal dysplasia with preand postnatal overgrowth and endocrine abnormalities. Am J Med Genet Part A. 2007;143A:1868-1875.
Doray B, Favre R, Viville B, Langer B, Dreyfus M, Stoll C. Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet. Jul-Dec 2000;43(3-4):163-9. [Medline].
Parilla BV, Leeth EA, Kambich MP, Chilis P, MacGregor SN. Antenatal detection of skeletal dysplasias. J Ultrasound Med. Mar 2003;22(3):255-8; quiz 259-61. [Medline].
Krakow D, Williams J 3rd, Poehl M, Rimoin DL, Platt LD. Use of three-dimensional ultrasound imaging in the diagnosis of prenatal-onset skeletal dysplasias. Ultrasound Obstet Gynecol. May 2003;21(5):467-72. [Medline].
Cassart M, Massez A, Cos T, et al. Contribution of three-dimensional computed tomography in the assessment of fetal skeletal dysplasia. Ultrasound Obstet Gynecol. May 2007;29(5):537-43. [Medline].
Teele RL. A guide to the recognition of skeletal disorders in the fetus. Pediatr Radiol. Jun 2006;36(6):473-84. [Medline].
[Guideline] Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med. Feb 2009;11(2):127-33. [Medline].
Thompson S, Shakespeare T, Wright MJ. Medical and social aspects of the life course for adults with a skeletaldysplasia: A review of current knowledge. Disabil Rehab. 2008;30:1-12.
Bethem D, Winter RB, Lutter L, et al. Spinal disorders of dwarfism. Review of the literature and report of eighty cases. J Bone Joint Surg Am. Dec 1981;63(9):1412-25. [Medline].
Bonnefoy O, Delbosc JM, Maugey-Laulom B, Lacombe D, Gaye D, Diard F. Prenatal diagnosis of hypochondroplasia: three-dimensional multislice computed tomography findings and molecular analysis. Fetal Diagn Ther. 2006;21(1):18-21. [Medline].
Bridges NA, Brook CG. Progress report: growth hormone in skeletal dysplasia. Horm Res. 1994;42(4-5):231-4. [Medline].
Chen H. Atlas of Genetic Diagnosis and Counseling. Totowa, New Jersey: Humana Press; 2006:1-1076.
Chen H. Genetic disorders. In: Liu PI, ed. Blue Book of Diagnostic Tests. Philadelphia, PA: WB Saunders Co; 1986:421-62.
Chen H. Skeletal dysplasias and mental retardation. In: Papadatos CJ, Bartsocas CS, eds. Skeletal Dysplasias. 1982. New York, NY: Alan R Liss Inc; 451-85.
Clark RN. Congenital dysplasias and dwarfism. Pediatr Rev. Nov 1990;12(5):149-59. [Medline].
Cohen MM Jr. The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A. Dec 1 2006;140(23):2646-706. [Medline].
Cormier-Daire V, Huber C, Munnich A. Allelic and nonallelic heterogeneity in dyschondrosteosis (Leri-Weill syndrome). Am J Med Genet. Winter 2001;106(4):272-4. [Medline].
Dominguez R, Talmachoff P. Diagnostic imaging update in skeletal dysplasias. Clin Imaging. Jul-Sep 1993;17(3):222-34. [Medline].
Dorst JP, Scott CI Jr, Hall JG. The radiologic assessment of short stature--dwarfism. Radiol Clin North Am. Aug 1972;10(2):393-414. [Medline].
Folstein SE, Weiss JO, Mittelman F, Ross DJ. Impairment, psychiatric symptoms, and handicap in dwarfs. Johns Hopkins Med J. Jun 1981;148(6):273-7. [Medline].
Fukami M, Okuyama T, Yamamori S, Nishimura G, Ogata T. Microdeletion in the SHOX 3' region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45,X/46,X,r(X) infant and Leri-Weill dyschondrosteosis in her 46,XX mother: implication for the SHOX enhancer. Am J Med Genet A. Aug 15 2005;137(1):72-6. [Medline].
Garjian KV, Pretorius DH, Budorick NE, Cantrell CJ, Johnson DD, Nelson TR. Fetal skeletal dysplasia: three-dimensional US--initial experience. Radiology. Mar 2000;214(3):717-23. [Medline].
Hall JG, Rimoin DL. Medical complications of dwarfing syndromes. In: Growth, Genetics and Hormones. Vol 4. 1988:6-9.
Hunter AG. Some psychosocial aspects of nonlethal chondrodysplasias: I. Assessment using a Life-Styles Questionnaire. Am J Med Genet. Jun 16 1998;78(1):1-8. [Medline].
Hurst JA, Firth HV, Smithson S. Skeletal dysplasias. Semin Fetal Neonatal Med. Jun 2005;10(3):233-41. [Medline].
Ilizarov GA. Clinical application of the tension-stress effect for limb lengthening. Clin Orthop. Jan 1990;(250):8-26. [Medline].
Jia L, Ho NC, Park SS, et al. Comprehensive resource: Skeletal gene database. Am J Med Genet. Winter 2001;106(4):275-81. [Medline].
Kennelly MM, Moran P. A clinical algorithm of prenatal diagnosis of Radial Ray Defects with two and three dimensional ultrasound. Prenat Diagn. Aug 2007;27(8):730-7. [Medline].
Lachman RS. International nomenclature and classification of the osteochondrodysplasias (1997). Pediatr Radiol. Oct 1998;28(10):737-44. [Medline].
Lachman RS, Rappaport V. Fetal imaging in the skeletal dysplasias. Clin Perinatol. Sep 1990;17(3):703-22. [Medline].
Leka SK, Kitsiou-Tzeli S, Kalpini-Mavrou A, Kanavakis E. Short stature and dysmorphology associated with defects in the SHOX gene. Hormones (Athens). Apr-Jun 2006;5(2):107-18. [Medline].
Ngo C, Viot G, Aubry MC, et al. First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness. Ultrasound Obstet Gynecol. Aug 2007;30(2):221-6. [Medline].
Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet. Aug 1986;23(4):328-32. [Medline].
Rimoin DL. Molecular defects in the chondrodysplasias. Am J Med Genet. May 3 1996;63(1):106-10. [Medline].
Rimoin DL, Lachman R, Unger S. Chondrodysplasias. In: Emery and Rimoin's Principles and Practice of Medical Genetics. Vol 3. 4th ed. London, England: Churchill Livingstone; 2002:4071-115.
Rimoin DL, Lachman RS. Genetic disorders of the osseous skeleton. In: Beighton P, ed. McKusick's Heritable Disorders of Connective Tissue. 5th ed. Mosby-Year Book; 1993:557-689.
Romero R, Athanassiadis AP, Jeanty P. Fetal skeletal anomalies. Radiol Clin North Am. Jan 1990;28(1):75-99. [Medline].
Ruano R, Molho M, Roume J, Ville Y. Prenatal diagnosis of fetal skeletal dysplasias by combining two-dimensional and three-dimensional ultrasound and intrauterine three-dimensional helical computer tomography. Ultrasound Obstet Gynecol. Aug 2004;24(2):134-40. [Medline].
Sillence DO, Rimoin DL, Lachman R. Neonatal dwarfism. Pediatr Clin North Am. Aug 1978;25(3):453-83. [Medline].
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979b;16:101-116.
Spirt BA, Oliphant M, Gottlieb RH, Gordon LP. Prenatal sonographic evaluation of short-limbed dwarfism: an algorithmic approach. Radiographics. Mar 1990;10(2):217-36. [Medline].
Unger S, Hecht JT. Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments. Am J Med Genet. Winter 2001;106(4):244-50. [Medline].
Yang SS. Skeletal system: Osteochondrodysplasias and dysostoses. In: Gilbert-Barness E, ed. Potter's Pathology of the Fetus and Infant. Vol 2. St Louis, Mo: Mosby-Year Book; 1997:1423-78.
Yasui N, Kawabata H, Kojimoto H, et al. Lengthening of the lower limbs in patients with achondroplasia and hypochondroplasia. Clin Orthop. Nov 1997;(344):298-306. [Medline].

